glp 1 receptor agonist diabetes GLP-1 agonists for individualized treatment of type 2 mellitus GLP-1 Agonists For Obesity In
Description
10.1042/CS20130708 50 SuhrsH
For this drug, the ongoing SOUL trial has shown promising preliminary results, indicating a 14% reduction in the risk of MACE (84)
Metoclopramide should only be used short-term (maximum 5 days) due to risk of neurological side effects, as highlighted in MHRA Drug Safety Updates
In addition, epidemiological studies have demonstrated that patients with Type 2 diabetes who used GLP-1 RAs were less likely to be diagnosed with nicotine misuse compared to those who used other medicines for Type 2 diabetes
Does Medicare Cover Scleral Lenses
